We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$42.7B
AUM Growth
+$3.67B
(+9.4%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
2,714
New
351
Increased
1,025
Reduced
1,076
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$367M |
| 2 |
Johnson & Johnson
JNJ
|
+$294M |
| 3 |
Fortinet
FTNT
|
+$260M |
| 4 |
General Mills
GIS
|
+$220M |
| 5 |
Rivian
RIVN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$485M |
| 2 |
Tesla
TSLA
|
+$476M |
| 3 |
Advanced Micro Devices
AMD
|
+$417M |
| 4 |
Coca-Cola
KO
|
+$344M |
| 5 |
Pfizer
PFE
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
ExxonMobil
XOM
$637B
| $13.8M | 0.03% |
138,036
+89,536
| +185% | +$9.41M |
|
427
BioCryst Pharmaceuticals
BCRX
$2.27B
| $13.6M | 0.03% |
2,268,012
-100,900
| -4% | -$585K |
|
428
Fastenal
FAST
$54.5B
| $13.6M | 0.03% |
419,400
+138,600
| +49% | +$4.18M |
|
429
ESAB
ESAB
$5.46B
| $13.6M | 0.03% |
156,800
+17,600
| +13% | +$1.33M |
|
430
BHP
BHP
$214B
| $13.6M | 0.03% |
198,600
-20,300
| -9% | -$1.23M |
|
431
Workday
WDAY
$39.2B
| $13.4M | 0.03% |
48,600
-15,700
| -24% | -$3.74M |
|
|
GES
432
DELISTED
Guess Inc
GES
| $13.2M | 0.03% |
573,502
+194,700
| +51% | +$4.35M |
|
433
Vita Coco
COCO
$3.85B
| $13.2M | 0.03% |
515,500
+52,400
| +11% | +$1.42M |
|
434
Mueller Industries
MLI
$14.9B
| $13.2M | 0.03% |
560,600
+257,000
| +85% | +$5.19M |
|
435
Huntsman Corp
HUN
$1.72B
| $13.2M | 0.03% |
525,400
+450,700
| +603% | +$11M |
|
436
Fortis
FTS
$29.2B
| $13.2M | 0.03% |
320,719
-214,300
| -40% | -$8.64M |
|
437
dLocal
DLO
$4.41B
| $13.2M | 0.03% |
744,000
+290,300
| +64% | +$5.19M |
|
438
Match Group
MTCH
$9.11B
| $13.1M | 0.03% |
357,800
+314,400
| +724% | +$10.6M |
|
439
First Financial Bankshares
FFIN
$5.04B
| $13.1M | 0.03% |
430,800
-1,300
| -0.3% | -$34.5K |
|
440
Dynatrace
DT
$12.7B
| $13M | 0.03% |
238,400
-528,498
| -69% | -$26.7M |
|
441
Amdocs
DOX
$5.79B
| $13M | 0.03% |
147,600
+119,000
| +416% | +$9.91M |
|
442
Lazard
LAZ
$4.11B
| $12.9M | 0.03% |
370,100
+68,700
| +23% | +$2.07M |
|
443
MasTec
MTZ
$20.8B
| $12.8M | 0.03% |
+169,500
| New | +$10.6M |
|
|
IAS
444
DELISTED
Integral Ad Science
IAS
| $12.8M | 0.03% |
891,100
+87,800
| +11% | +$1.17M |
|
|
CMA
445
DELISTED
Comerica
CMA
| $12.8M | 0.03% |
228,700
+32,200
| +16% | +$1.46M |
|
446
Jacobs Solutions
J
$15.9B
| $12.7M | 0.03% |
117,875
-37,599
| -24% | -$4.09M |
|
|
PINC
447
DELISTED
Premier
PINC
| $12.7M | 0.03% |
565,900
-103,600
| -15% | -$2.14M |
|
448
Kadant
KAI
$3.64B
| $12.6M | 0.03% |
45,100
+11,000
| +32% | +$2.75M |
|
449
ADMA Biologics
ADMA
$1.95B
| $12.6M | 0.03% |
2,777,600
-388,500
| -12% | -$1.44M |
|
450
ASML
ASML
$632B
| $12.5M | 0.03% |
16,500
-20,200
| -55% | -$13.3M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Advisers held 2,714 positions worth $42.7B, up 9.4% from $39B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers withdrew a net $1.56B in Q4 2023, closing 234 positions and reducing 1,076 holdings. Its most notable exit was Palo Alto Networks, an estimated $281M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Two Sigma Advisers opened a new position in Block Inc worth $238M.
- Two Sigma Advisers's largest Q4 2023 buy was Block Inc: 3,076,207 shares worth $238M.
- Two Sigma Advisers added most to Merck in Q4 2023, an estimated $367M increase.
- Two Sigma Advisers's biggest Q4 2023 reduction was Nike, cutting an estimated $485M.
- Two Sigma Advisers fully exited Palo Alto Networks in Q4 2023, selling an estimated $281M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $42.7B portfolio in Q4 2023.
- Two Sigma Advisers opened 351 new positions and closed 234 in Q4 2023.
- Two Sigma Advisers's portfolio value rose 9.4% quarter-over-quarter to $42.7B.
Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.